GILEAD SCIENCES, INC. XLO Holdings History

Number of Shares
9.11 Mil
Current Holdings Value*
$6.60 Mil
% of Portfolio
0.56%
Total Estimate Gain
$-2.55 Mil
% of Total Estimate Gain
-28.26%

GILEAD SCIENCES, INC.'s Xilio Therapeutics Inc Holding Summary

As of 2025-03-31, GILEAD SCIENCES, INC. held 9.11 Mil shares of Xilio Therapeutics Inc(XLO), totaling $6.60 Mil. This investment constitutes 0.56% of their stock portfolio, and GILEAD SCIENCES, INC. now holds 17.58% of the outstanding Xilio Therapeutics Inc(XLO) stock.

The initial trade took place in 2024Q4. Based on historical transaction data and XLO's current price of $0.71, GILEAD SCIENCES, INC.'s estimated gain on his XLO holdings is $-2.55 Mil, reflecting a -28.26% gain to date.

GILEAD SCIENCES, INC. XLO ($0.71) Holding Chart

GILEAD SCIENCES, INC. XLO ($0.71) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1